Valeant has sold its controversial female libido drug to former shareholders in Sprout ... Now the company’s new management team led by CEO Joseph Papa has decided to move it on, selling ...

Beginning with the drug's US launch in mid-October, doctors who frequently see patients complaining about a loss of sexual appetite will have a new option ... to boost women's libido, a use ...

These new, Barbie-pink gummies for women are out next month (SUBS ... The “Turn Me On” gummies are of course not drugs, they ...

In the United States, two drugs have been approved to treat female sexual interest/arousal ... describes the FDA-approved medications for low libido in females, including how they work and the ...

Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

Hall scheduled an appointment with a specialist, and in 2024 started testosterone replacement therapy (TRT)—receiving regular ...

Having taken on the development of flibanserin from Boehringer Ingelheim and put the drug for a problem with female libido through a new programme of clinical development, Sprout Pharmaceuticals ...

has approved a libido-enhancing drug for women that has been dubbed “Female Viagra”. Flibanserin, a drug produced by Sprout Pharmaceuticals, recently passed an FDA advisory committee meeting.

A BBC report reveals that women prescribed drugs for Restless Leg Syndrome experienced drastic changes in behaviour.

Yet, she says: “many women are frustrated by the lack of libido that this brings ... In 2023, however, a major study ...

And this week, the Oscar-winning star has been questioning the effects - and apparent lack of visibility - of a drug called Addyi, first released in 2015, which is said to boost female libido. The ...

Patients prescribed drugs for ... about increased libido and harmful behaviour. GSK says a risk of "altered" sexual interest is also referred to in the leaflets. Some of the women who described ...